Etiology of fibrous dysplasia and McCune-Albright syndrome

International Journal of Oral and Maxillofacial Surgery

Volumn 28, Issue 5, 1999, Pages 366-371

  Cohen Jr , M Michael ^a   Howell, Robin E ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Dalhousie University ^*

Author keywords

Fibrous dysplasia; G protein; GNAS1 gene; Mccune Albright syndrome; Neoplasia; Pituitary adenoma; Somatic mosaicism

Indexed keywords

EID: 0033212348     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0901-5027(99)80085-x     Document Type: Article

References (39)

1. ALMAN BA, GREEL DA, et al. Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 1996: 14 (2): 311-5.
2. sα-mutated skeletal progenitor cells. J Clin Invest 1998: 101 (8): 1737-44.
3. CANDELIERE GA, ROUGHLEY PJ, GLORIEUX FH. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 1997: 21: 201-6.
4. CANDELIERE GA, GLORIEUX FH, PRUD'-HOMME J, et al. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995: 332: 1546-51.
5. CLAPHAM DE, NEER EJ. New roles for G-protein βγ-dimers in transmembrane signalling. Nature 1993: 365: 403-6.
6. COHEN MM JR. Nevoid basal cell carcinoma syndrome: molecular biology and new hypotheses. Int J Oral Maxillofac Surg 1999: 28: 216-23.
7. COHEN MM JR. The child with multiple birth defects. New York: Oxford University Press, 1997.
8. COLE DEC, COHEN MM JR. Mutations affecting bone-forming cells. In: HALL BK, ed.: Bone. Volume I. The osteoblast and osteocyte. Caldwell, NJ: Telford Press, 1990: 431-87.
9. COLE DEC, COHEN MM JR. Mutations affecting bone-forming cells. In: HALL BK, ed.: Bone. Volume I. The osteoblast and osteocyte. Caldwell, NJ: Telford Press, 1990: 431-87.
10. FAGLIA G, AROSIO M, SPADA A. GS protein mutations and pituitary tumors: Functional correlates and possible therapeutic implications. Metabolism 1996: 45 (8 Suppl 1): 117-9.
11. HAPPLE R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet 1986: 29: 321-4.
12. HARRIS PE. Gs protein mutations and the pathogenesis and function of pituitary tumors. Metabolism 1996: 45 (8 Suppl 1): 120-2.
13. HAYWARD BE, MORAN V, STRAIN L, et al. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci U S A 1998 95: 15475-80.
14. JUPPNER H, SCHIPANI E, BASTEPE M, et al. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci U S A 1998: 95: 11798-803.
15. LANDIS CA, MASTERS SB, SPADA A, et al. GTPase inhibiting mutations activate the alpha chain of G(s) and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989: 340: 692-6.
16. LEVINE MA, MODI WS, O'BRIEN SJ. Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2-q13.3 in human by in situ hybridization. Genomics 1991: 11: 478-9.
17. MALCHOFF CD, REARDON G, MACGILLIVRARY DC, et al. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the G(s) alpha-subunit from a bone lesion. J Clin Endocrinol Metab 1994: 78: 803-6.
18. MARIE PJ, DE POLLAK C, CHANSON P, et al. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 1997: 150: 1059-69.
19. REGEZI JA, SCIUBBA JJ. Oral pathology: clinical pathologic correlations. Fourth edition. Philadelphia: W.B. Saunders Co., 1999.
20. RIMINUCCI M, FISHER LW, SHENKER A, et al. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997: 151: 1587-600.
21. sα gene: site-specific patterns and recurrent histological hallmarks. J Pathol 1999: 187: 249-58.
22. RUTHER U, GARBER C, KOMITOWSKI D, et al. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 1987: 325: 412-6.
23. RUTHER U, KOMITOWSKI D, SCHUBERT FR, et al. C-fos expression induces bone tumors in transgenic mice. Oncogene 1989: 4: 861-5.
24. 90 as a capacitor for morphological evolution. Nature 1998: 396: 336-42.
25. SCHWARTZ DT, ALPERT M. The malignant transformation of fibrous dysplasia. Am J Med Sci 1964: 247: 1.
26. SCHWINDINGER WF, FRANCOMANO CA, LEVINE MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G-protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 1992: 89: 5152-6.
27. SHAFER WG, HINE MK, LEVY BM. A textbook of oral pathology. Fourth edition. Philadelphia: W.B. Saunders Co., 1983.
28. SHENKER A, CHANSON P, WEINSTEIN LS, et al. Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the G(S)-alpha gene. Hum Mol Genet 1995: 4: 1675-6.
29. SHENKER A, WEINSTEIN LS, SWEET DE, et al. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994: 79: 750-5.
30. SHENKER A, WEINSTEIN LS, MORAN A, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr 1993: 123: 509-18.
31. SHENKER A. Activating mutations in G protein-coupled signaling pathways as a cause of endocrine disease. Growth Genet Horm 1996: 12: 33-7.
32. SPIEGEL AM. The molecular basis of disorders caused by defects in G proteins. Horm Res 1997: 47: 89-96.
33. TANNER HC JR, DAHLIN DC, CHILDS DS JR. Sarcoma complicating fibrous dysplasia. Probable role of radiation therapy. Oral Surg 1961: 14: 837.
34. WALDRON CA, GIANSANTI JS. Benign flbro-osseous lesions of the jaws: a clinical-radiologic-histologic review of sixty-five cases. Oral Surg 1973: 35: 340-50.
35. WEINSTEIN LS, SHENKER A, GEJMAN PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991: 325: 1688-95.
36. WILLIAMSON EA, INCE PG, HARRISON D, et al. G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 1995: 25: 128-31.
37. WU J-X, CARPENTER PM, GRESENS C, et al. The proto-oncogene c-fos is overexpressed in the majority of human osteosarcomas. Oncogene 1990: 5: 989-1000.
38. YABUT SM JR, KENAN S, SISSONS HA, et al. Malignant transformation of fibrous dysplasia: a case report and review of the literature. Clin Orthop 1988: 228: 281-8.
39. sα gene. Proc Natl Acad Sci U S A 1998: 95: 8715-20.